SCHEMBL2815259

SCHEMBL2815259

COC(=O)/C(=C/Sc1ccc(F)cc1)Sc1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.37
LMNA P02545 1/20 0.37
HTT P42858 1/20 0.37
SLC6A4 P31645 1/20 0.35
SLC6A3 Q01959 1/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
CA12 O43570 1/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
CA9 Q16790 1/20 0.35
NPC1 O15118 2/20 0.35
GLA P06280 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
TERT O14746 1/20 0.35
RAB9A P51151 2/20 0.34
TDP1 Q9NUW8 1/20 0.34
GAA P10253 1/20 0.33
KDM4E B2RXH2 1/20 0.33
MAPT P10636 1/20 0.33
HPGD P15428 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2815262 1.00 ALDH1A1 (0.37) ALDH1A1LMNAHTTSLC6A4SLC6A3
SCHEMBL2812454 0.91 LMNA (0.38) ALDH1A1LMNAHTTSMN1; SMN2L3MBTL1
SCHEMBL2812455 0.91 LMNA (0.38) ALDH1A1LMNAHTTSMN1; SMN2L3MBTL1
SCHEMBL2811362 0.84 ALDH1A1 (0.38) ALDH1A1LMNAHTTSMN1; SMN2NPC1
SCHEMBL2811360 0.84 ALDH1A1 (0.38) ALDH1A1LMNAHTTSMN1; SMN2NPC1
SCHEMBL2808673 0.82 NPC1 (0.40) ALDH1A1HTTSMN1; SMN2NPC1L3MBTL1
SCHEMBL2808675 0.82 NPC1 (0.40) ALDH1A1HTTSMN1; SMN2NPC1L3MBTL1
SCHEMBL2808862 0.80 NPC1 (0.44) ALDH1A1LMNAHTTSMN1; SMN2NPC1
SCHEMBL2808865 0.80 NPC1 (0.44) ALDH1A1LMNAHTTSMN1; SMN2NPC1
SCHEMBL2812788 0.79 MAPT (0.38) ALDH1A1LMNAHTTSMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8278473-B2 Alpha, beta-unsaturated imidate compound and pesticidal composition containing the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-10-02 US disclosed
US-20100240729-A1 ALPHA, BETA-UNSATURATED IMIDATE COMPOUND AND PESTICIDAL COMPOSITION CONTAINING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-09-23 US disclosed
WO-2009064031-A1 ALPHA, BETA-UNSATURATED IMIDATE COMPOUND AND PESTICIDAL COMPOSITION CONTAINING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-05-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100240729-A1 ALPHA, BETA-UNSATURATED IMIDATE COMPOUND AND PESTICIDAL COMPOSITION CONTAINING THE SAME OXER1, CBR1, DEGS1 ALDH1A1 405/4885LMNA 2201/4885HTT 4084/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.